JP2022521460A5 - - Google Patents

Info

Publication number
JP2022521460A5
JP2022521460A5 JP2021544720A JP2021544720A JP2022521460A5 JP 2022521460 A5 JP2022521460 A5 JP 2022521460A5 JP 2021544720 A JP2021544720 A JP 2021544720A JP 2021544720 A JP2021544720 A JP 2021544720A JP 2022521460 A5 JP2022521460 A5 JP 2022521460A5
Authority
JP
Japan
Prior art keywords
cytidine
deaminase
nucleic acid
base editor
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021544720A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022521460A (ja
JP7600122B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/016288 external-priority patent/WO2020160517A1/en
Publication of JP2022521460A publication Critical patent/JP2022521460A/ja
Publication of JP2022521460A5 publication Critical patent/JP2022521460A5/ja
Priority to JP2024210915A priority Critical patent/JP7779988B2/ja
Application granted granted Critical
Publication of JP7600122B2 publication Critical patent/JP7600122B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021544720A 2019-01-31 2020-01-31 低減されたオフターゲット脱アミノ化を有する核酸塩基エディターおよび核酸塩基標的配列を改変するためのその使用方法 Active JP7600122B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024210915A JP7779988B2 (ja) 2019-01-31 2024-12-04 低減されたオフターゲット脱アミノ化を有する核酸塩基エディターおよび核酸塩基標的配列を改変するためのその使用方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962799702P 2019-01-31 2019-01-31
US62/799,702 2019-01-31
US201962835456P 2019-04-17 2019-04-17
US62/835,456 2019-04-17
US201962941569P 2019-11-27 2019-11-27
US62/941,569 2019-11-27
PCT/US2020/016288 WO2020160517A1 (en) 2019-01-31 2020-01-31 Nucleobase editors having reduced off-target deamination and methods of using same to modify a nucleobase target sequence

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024210915A Division JP7779988B2 (ja) 2019-01-31 2024-12-04 低減されたオフターゲット脱アミノ化を有する核酸塩基エディターおよび核酸塩基標的配列を改変するためのその使用方法

Publications (3)

Publication Number Publication Date
JP2022521460A JP2022521460A (ja) 2022-04-08
JP2022521460A5 true JP2022521460A5 (cg-RX-API-DMAC7.html) 2023-02-03
JP7600122B2 JP7600122B2 (ja) 2024-12-16

Family

ID=71842357

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021544720A Active JP7600122B2 (ja) 2019-01-31 2020-01-31 低減されたオフターゲット脱アミノ化を有する核酸塩基エディターおよび核酸塩基標的配列を改変するためのその使用方法
JP2024210915A Active JP7779988B2 (ja) 2019-01-31 2024-12-04 低減されたオフターゲット脱アミノ化を有する核酸塩基エディターおよび核酸塩基標的配列を改変するためのその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024210915A Active JP7779988B2 (ja) 2019-01-31 2024-12-04 低減されたオフターゲット脱アミノ化を有する核酸塩基エディターおよび核酸塩基標的配列を改変するためのその使用方法

Country Status (8)

Country Link
US (1) US20220136012A1 (cg-RX-API-DMAC7.html)
EP (1) EP3918077A4 (cg-RX-API-DMAC7.html)
JP (2) JP7600122B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210124280A (cg-RX-API-DMAC7.html)
CN (2) CN114072509B (cg-RX-API-DMAC7.html)
AU (1) AU2020216484A1 (cg-RX-API-DMAC7.html)
CA (1) CA3127494A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020160517A1 (cg-RX-API-DMAC7.html)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
WO2018165504A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Suppression of pain by gene editing
EP3676376B1 (en) 2017-08-30 2025-01-15 President and Fellows of Harvard College High efficiency base editors comprising gam
US12406749B2 (en) 2017-12-15 2025-09-02 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
WO2019217942A1 (en) 2018-05-11 2019-11-14 Beam Therapeutics Inc. Methods of substituting pathogenic amino acids using programmable base editor systems
WO2019226953A1 (en) 2018-05-23 2019-11-28 The Broad Institute, Inc. Base editors and uses thereof
EP3820495A4 (en) 2018-07-09 2022-07-20 The Broad Institute Inc. RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES
EP3850088A4 (en) 2018-09-07 2023-07-19 Beam Therapeutics, Inc. Compositions and methods for improving base editing
KR20210055733A (ko) 2018-09-07 2021-05-17 빔 테라퓨틱스, 인크. 핵염기 편집 시스템을 전달하기 위한 조성물 및 방법
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
JP7646552B2 (ja) 2019-01-31 2025-03-17 ビーム セラピューティクス インク. 低減された非標的脱アミノ化を有する核酸塩基エディターおよび核酸塩基エディターの特徴づけのためのアッセイ
US12600971B2 (en) 2019-02-13 2026-04-14 Beam Therapeutics Inc. Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence
WO2020168135A1 (en) 2019-02-13 2020-08-20 Beam Therapeutics Inc. Compositions and methods for treating alpha-1 antitrypsin deficiency
WO2020191241A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
WO2020214842A1 (en) 2019-04-17 2020-10-22 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
US12594301B2 (en) 2019-09-27 2026-04-07 Beam Therapeutics Inc. Compositions and methods for treatment of liquid cancers
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
EP4103705A4 (en) * 2020-02-14 2024-02-28 Ohio State Innovation Foundation Nucleobase editors and methods of use thereof
CA3177481A1 (en) 2020-05-08 2021-11-11 David R. Liu Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
AU2021347359A1 (en) 2020-09-25 2023-05-18 Beam Therapeutics Inc. Fratricide resistant modified immune cells and methods of using the same
BR112023019539A2 (pt) * 2021-03-26 2023-12-05 Beam Therapeutics Inc Variantes de adenosina desaminase e usos das mesmas
EP4323501A1 (en) * 2021-04-16 2024-02-21 Beam Therapeutics Inc. Genetic modification of hepatocytes
WO2022261509A1 (en) * 2021-06-11 2022-12-15 The Broad Institute, Inc. Improved cytosine to guanine base editors
EP4396207A4 (en) * 2021-09-03 2025-07-16 Univ Chicago POLYPEPTIDES AND METHODS FOR MODIFYING NUCLEIC ACIDS
WO2023086953A1 (en) * 2021-11-11 2023-05-19 Beam Therapeutics Inc. Compositions and methods for the treatment of hereditary angioedema (hae)
CN114686456B (zh) * 2022-05-10 2023-02-17 中山大学 基于双分子脱氨酶互补的碱基编辑系统及其应用
EP4540378A1 (en) * 2022-06-20 2025-04-23 CRISPR Therapeutics AG Base editing proteins and uses thereof
CN117343921A (zh) * 2022-07-05 2024-01-05 华东师范大学 胞嘧啶碱基编辑器及其应用
US20260139238A1 (en) * 2022-10-19 2026-05-21 Dna Script Methods and products for removal of uracil containing polynucleotides
WO2024125313A1 (zh) * 2022-12-15 2024-06-20 中国科学院遗传与发育生物学研究所 一种碱基编辑器及其应用
CN120699942A (zh) * 2023-02-28 2025-09-26 锐正基因(苏州)有限公司 用于碱基编辑的脱氨酶
CN118871578A (zh) 2023-05-24 2024-10-29 锐正基因(苏州)有限公司 用于碱基编辑的脱氨酶及其变体
CN117210445A (zh) * 2023-08-29 2023-12-12 苏州湃芮生物科技有限公司 一种基于rna特异性脱氨酶突变体及其应用
CN120813698A (zh) * 2023-09-22 2025-10-17 北京大学现代农业研究院 改进的基因组编辑方法
CN122349566A (zh) * 2023-12-06 2026-07-07 北京齐禾生科生物科技有限公司 优化的qbe碱基编辑系统及其应用
WO2025202473A1 (en) * 2024-03-28 2025-10-02 Revvity Discovery Limited A nucleic acid deaminase, a base editor and uses thereof
WO2025240372A1 (en) * 2024-05-13 2025-11-20 Metagenomi, Inc. Compositions and methods for editing t cells
CN121087015A (zh) * 2025-11-03 2025-12-09 中国农业大学 编辑效率提高的Casδ变体及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150166984A1 (en) * 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting alpha-antitrypsin point mutations
WO2017070632A2 (en) * 2015-10-23 2017-04-27 President And Fellows Of Harvard College Nucleobase editors and uses thereof
WO2018027078A1 (en) * 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
IL306092A (en) * 2017-03-23 2023-11-01 Harvard College Nucleic base editors that include nucleic acid programmable DNA binding proteins
EP3625342B1 (en) * 2017-05-18 2022-08-24 The Broad Institute, Inc. Systems, methods, and compositions for targeted nucleic acid editing
CA3063733A1 (en) * 2017-05-25 2018-11-29 The General Hospital Corporation Base editors with improved precision and specificity
WO2019084062A1 (en) * 2017-10-23 2019-05-02 The Broad Institute, Inc. SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITION
KR102959497B1 (ko) * 2018-05-11 2026-05-04 빔 테라퓨틱스, 인크. 프로그래밍가능한 염기 편집기 시스템을 이용하여 병원성 돌연변이를 억제하는 방법
WO2019226953A1 (en) * 2018-05-23 2019-11-28 The Broad Institute, Inc. Base editors and uses thereof
KR102894715B1 (ko) * 2018-08-03 2025-12-03 빔 테라퓨틱스, 인크. 핵산 표적 서열을 변형시키기 위한 다중-이펙터 핵염기 편집기 및 이를 이용하는 방법
KR20210116526A (ko) * 2019-01-16 2021-09-27 빔 테라퓨틱스, 인크. 증진된 항-신생물 활성 및 면역억제 내성을 갖는 변형된 면역 세포

Similar Documents

Publication Publication Date Title
JP2025041661A5 (cg-RX-API-DMAC7.html)
CN111065647B (zh) 用于提高碱基编辑精度的融合蛋白
Barreto et al. AID from bony fish catalyzes class switch recombination
MOCHIZUKI et al. Characterization of a plant SINE, p-SINE1, in rice genomes
Navaratnam et al. An overview of cytidine deaminases
US20240209332A1 (en) Enzymes with ruvc domains
Bresson et al. Lesion bypass in yeast cells: Pol η participates in a multi‐DNA polymerase process
KR102515049B1 (ko) Cas9 변이체 및 그의 용도
JP2023052051A5 (cg-RX-API-DMAC7.html)
KR20250107288A (ko) 아데노신 염기 편집제의 용도
JP2022519507A5 (cg-RX-API-DMAC7.html)
WO2016082135A1 (zh) 一种利用定点切割系统对猪h11位点定点插入的方法
JP2016165307A5 (cg-RX-API-DMAC7.html)
JP2017500035A (ja) 遺伝子編集用のcas多様体
CN114438110B (zh) 一种精确无pam限制的腺嘌呤碱基编辑器及其构建方法
JP2024541811A5 (cg-RX-API-DMAC7.html)
US12435323B2 (en) Enzymes with RUVC domains
CN112048497B (zh) 一种新型的单碱基编辑技术及其应用
US12006519B2 (en) Polymerase mutants and use with 3′-OH unblocked reversible terminators
JP2021522825A5 (cg-RX-API-DMAC7.html)
CN118871578A (zh) 用于碱基编辑的脱氨酶及其变体
WO2025119385A1 (zh) 一种具有三碱基编辑功能的融合蛋白及其应用
CN115703842A (zh) 高效率高精度的胞嘧啶c到鸟嘌呤g转变的碱基编辑器
Li et al. Nucleases in gene-editing technologies: past and prologue
Bonavita et al. The evolutionary conservation of rps3 introns and rps19-rps3-rpl16 gene cluster in Adiantum capillus-veneris mitochondria